UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

Benzinga Newsdesk www.benzinga.com Positive 62.8%

Neg 0% Neu 0% Pos 62.8%

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $21 to $22.